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Abstract
High-throughput molecular methods are currently exploited to characterize the complex and highly individual intestinal microbiota in
health and disease. Definition of the human intestinal core microbiota, i.e. the number and the identity of bacteria that are shared
among different individuals, is currently one of the main research questions. Here we apply a high-throughput phylogenetic microarray,
for a comprehensive and high-resolution microbiota analysis, and a novel computational approach in a quantitative study of the core
microbiota in over 100 individuals. In the approach presented we study how the criteria for the phylotype abundance or prevalence
influence the resulting core in parallel with biological variables, such as the number and health status of the study subjects. We
observed that the core size is highly conditional, mostly depending on the depth of the analysis and the required prevalence of the core
taxa. Moreover, the core size is also affected by biological variables, of which the health status had a larger impact than the number of
studied subjects. We also introduce a computational method that estimates the expected size of the core, given the varying prevalence
and abundance criteria. The approach is directly applicable to sequencing data derived from intestinal and other host-associated micro-
bial communities, and can be modified to include more informative definitions of core microbiota. Hence, we anticipate its utilization
will facilitate the conceptual definition of the core microbiota and its consequent characterization so that future studies yield conclusive
views on the intestinal core microbiota, eliminating the current controversy.
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Introduction
From birth the gastrointestinal (GI) microbiota constitute the
largest microbial ecosystem of the human body. Recent stud-
ies with culture-independent molecular methods have
revealed that, while the exact GI microbiota composition is
highly individual specific [1], a typical gut ecosystem harbours
thousands of phylotypes from less than ten bacterial phyla
dominated by the Firmicutes, Bacteroidetes, Actinobacteria,
Proteobacteria and Verrucomicrobia. The collective genome
of the intestinal microbes vastly surpasses the coding capacity
of the human genome with more than 3 million genes [2].
Hence, we are composite organisms co-programmed by the
inherited human genome and the environmentally acquired
microbiome. The health relevance of the GI microbiome lies
in its capacity to provide the host with vital and irreplaceable
functions ranging from the energy and vitamin metabolism to
epithelial barrier integrity and immune modulation [3].
The vast majority of the GI tract microbes have not yet
been cultured and are only recognized with molecular meth-
ods based on 16S rDNA sequences. A panoply of high-
throughput approaches have been developed to describe the
GI microbiota, including deep new generation sequence analy-
sis and phylogenetic microarrays [1]. Using these approaches,
the loss of homeostasis in the host–microbe symbiosis has
recently been associated with a wide variety of intestinal and
systemic diseases (reviewed in [4]). Disease-associated com-
positional and functional alterations of the GI microbiota are
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actively being investigated. However, the immense complexity
and large inter-individual variability of the microbiota hamper
the current ability to resolve differences between the bacte-
rial communities of patients and controls and call for robust
and sufficiently powered studies to get an insight into the
microbial aetiology of specific diseases.
Despite the accumulating data provided by modern molec-
ular techniques, current knowledge does not yet offer a defi-
nition for a normal or optimal GI microbiota composition. In
parallel with mining the entire diversity of host-associated
microbial communities, recently significant effort has been
devoted to a more focused approach that aims to define a
core microbiota that is potentially shared across adult indi-
viduals [2,5–10]. The specific interest towards universally
shared bacteria arises from the fact that, in contrast to tran-
sient gut inhabitants that fluctuate depending on the diet and
other environmental factors, the common core bacteria are
conserved during the mutual coevolution of man and his
intestinal microbes. Consequently, the core microbiota is
anticipated to represent a selected set of health-associated
symbionts. Once catalogued, the targeted characterization of
the core bacteria would provide a scientifically sound and
economically relevant strategy to access the GI microbes
that are the most relevant for human health and may hold
diagnostic or therapeutic potential. Although the basic defini-
tion of the core microbiota is intuitive, there are currently
several unaddressed questions relating to its biological and
analytical parameters. How many individuals need to be stud-
ied? Should their overall or even intestinal health status be
defined and, if yes, based on which parameters [11]? Do we
qualify only bacteria that are detected in 100% of the individ-
uals or is a lower prevalence threshold justifiable to provide
robustness against technical variation? Finally, are we inter-
ested only in the dominant bacteria or should we use analyti-
cal methods that also allow mining of the rare intestinal
biosphere?
Owing to lack of the above-mentioned definitions, the
number and health status of the study subjects as well as the
required prevalence for core species has varied considerably
among current studies describing the human intestinal core
microbiota. Moreover, the effect of analysis depth has so far
been largely ignored. Current estimates of the taxonomic
overlap between individuals range from 0–2% [5,6] to over
30% [2,7] and thus lack consensus. To tackle the current
controversy, we carried out phylogenetic microarray analysis
of the GI microbiota derived from more than 100 individuals.
The data were used to examine the impact of analytical res-
olution (depth) and coverage (width) as well as of biological
variables (subject number and health status) as determinants
of the common core microbiota.
Materials and Methods
The data set used consisted of faecal microbiota profiles
obtained by the Human Intestinal Tract Chip (HITChip), a
phylogenetic microarray covering over 1000 different intesti-
nal phylotypes [9]. Single time point HITChip profiles from
127 unrelated European individuals that were derived
from ongoing clinical or observational trials were extracted
from an in-house data collection of over 1000 microarray
experiments [12]. The main data set was composed of 115
healthy subjects, devoid of GI or other diseases. The mean
age of the subjects was 40, the mean body mass index was
24 kg/m2 and two-thirds of the subjects were female. To
benchmark the healthy microbiota, we used as a reference
HITChip data measured from faecal samples collected from
12 ulcerative colitis (UC) patients. The faecal samples were
collected and stored according to established procedures and
the faecal DNA was extracted as previously described [12].
All HITChip microarray analyses and computational pre-
processing including signal thresholding were performed as
previously described [9,10]. The analysis was carried out
using phylotype (species-like) level signals that were esti-
mated from the hybridizing HITChip probes by using the
robust probabilistic averaging algorithm [13]. This method
provides a robust estimate of the average signal of the HIT-
Chip probes targeting the same phylotype by giving less
weight to probes showing sensitivity to noise attributable to
unintended cross-hybridization with non-target sequences. It
is anticipated that this method reduces the number of false
positives in the common core analysis.
In rarefaction analysis, for each sample size a set of
10 000 bootstrap replicates were sampled from the full data
set of healthy or UC patients. For each set, the detection
threshold was chosen randomly from a uniform distribution
between the minimum detection threshold and the observed
maximum intensity, and the number of detected species was
counted. The common core microbiota was addressed by
thresholding the HITChip phylotype (species-like) level data
in a grid of logarithmic signal intensity (range 1.93–4.98) and
prevalence (number of carriers, range 1–115) as previously
described [12]. The resulting surface was visualized with a
perspective plot [14].
The number of common microbes in an arbitrary set of
samples was estimated by bootstrapping, where in each
bootstrap set the intensity threshold was selected randomly
and the number of common microbes was computed. The
set of phylotypes belonging to the core microbiota of UC or
healthy patients was estimated from 10 000 bootstrap sam-
ples where, in addition to the intensity threshold also the
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prevalence was selected randomly. Additionally, to balance
the difference in sizes between the two data sets (UC vs
healthy), 12 samples from healthy patients were chosen for
each bootstrap round. The results were collected into a fre-
quency table reporting the number of times each phylotype
fulfilled the criteria. The core sizes estimated above were
then invoked to select the most frequently occurring phylo-
types in the core microbiota of the UC or healthy patients.
All data analyses were performed in R version 2.12.1 [15].
Results
We addressed the common core of the human GI microbi-
ota by using high-resolution and highly reproducible micro-
array data sets derived from over 100 individuals that were
mined with a flexible computational approach. To generate
an overview of the data, we carried out principal component
analysis and hierarchical clustering that ensured sufficient
homogeneity of the data to carry out the meta-level analysis
of the common core (data not shown).
To estimate the representativeness of the data set, and to
assess how many individuals are actually needed to reliably
determine the core size, we performed a rarefaction analysis
for the detected phylotypes (Fig. 1). We observed that
already in a set of only a few dozen subjects the vast major-
ity of the total richness was captured, indicated by the level-
ling of the line towards the horizontal. However, there was
no plateau in the number of detected phylotypes, signifying a
constant increase in the detected richness even after 100
individuals (Fig. 1). Altogether, the rarefaction analysis indi-
cated that the number of samples provided a sufficient and
representative data set to address the core microbiota.
In the absence of consensus criteria for the analytical
common core parameters, we included the complete range
of abundance and prevalence values, from minimum to maxi-
mum. The HITChip signal intensities varied over 1000-fold
(log10 ratio of 3.1), signifying high variability in the abundance
of the phylotypes. All possible prevalence values were
accommodated, denoting the presence of a given phylotype
in 1–115 subjects. As a result, the common core size appears
as a continuum from zero to several hundreds of phylotypes,
depending on the selected abundance and prevalence values
as visualized with a perspective plot (Fig. 2a). Plotting the
number of core phylotypes on different abundance thresh-
olds visualizes the strong dependence between these factors
(Fig. 2b). Consequently, there was no common core if a
phylotype was required to be present in high abundance
(>2.5% of the total signal) in all subjects, but when we
included also the low abundance bacteria, as many as 30%
(290 phylotypes) of the microbiota were shared by all 115
individuals. The true core size should lie somewhere
between these two extremes.
To estimate the true core size, we computed the mean
core size that could be detected in a random sample of
healthy individuals. We required absolute (100%) prevalence
in 115 individuals and applied bootstrap analysis to average
over different abundance thresholds between the minimum
and maximum (Fig. 3). The expected number of shared phyl-
otypes in the given cohort was around 100 phylotypes.
Notably, the size of the core levelled off fast, suggesting that
the mean core size can be estimated already from a few
healthy individuals.
The effect of health status on the core size was analysed
by including HITChip data from 12 UC patients in the data
set and comparing them with the microbiota of 12 healthy
subjects derived with the bootstrap procedure. Separate
analysis of the UC and healthy cores indicated a significantly
smaller core size in the UC patients (Fig. 4a). This finding
was confirmed by pooling the UC and healthy data sets,
which yielded a core size intermediate between the health-
status-specific ones. To study the compositional overlap
between the healthy and UC cores, a comparative analysis
was carried out (Fig. 4b). Altogether 58% of the core phylo-
types were common and thus independent of health status,
while 25% and 17% were specific to healthy or UC subjects,
respectively.
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FIG. 1.Overview of the total phylotype richness in 115 healthy sub-
jects. Rarefaction curve showing the number of phylotypes (y-axis)
that are detected after analysing the number of subjects shown on
the x-axis. Dashed lines indicate the 95% confidence intervals of the
mean.
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Discussion
In this work we utilized one of the largest human gut micro-
biota data sets available, consisting of 16S rRNA gene-based
high-resolution microarray profiles. Collective data from
over 100 subjects were analysed using a novel computational
approach to characterize the common core microbiota in
healthy subjects, and to test the impact of three key vari-
ables in the common core analysis: (i) analysis depth, by
using different abundance thresholds for the phylotypes;
(ii) number of subjects, by carrying out rarefaction and boot-
strap analyses; and (iii) the health status of the subjects, by
including microbiota of UC patients.
Our results show that the core size is highly conditional,
depending on both technical and biological variables, i.e. the
depth of the analysis, the prevalence of the taxa as well as
the number and health status of the study subjects. The
deterministic impact of the coverage of analysis has been indi-
cated also in a previous study where doubling of the sequenc-
ing depth increased the amount of shared phylotypes by 25%
[2]. So far, most studies on core microbiota have targeted
the phylotypes that are predominant in all individuals and thus
have excluded a substantial part as the abundance of phylo-
types may vary over 2000-fold across individuals [2].
By using a criterion of 100% prevalence and including also
the low abundant phylotypes, we found that one-third of
these were shared among the 115 healthy subjects. The pro-
portion of shared phylotypes reported here is considerably
larger than those reported previously in sequencing-derived
estimates, which have ranged from 0–2% [5,6] to about 30%
[2,7] using notably lower stringency for the prevalence
(‡50%). It should be noted that while sequencing discovers
novel sequences, microarrays are limited to previously
detected phylotypes for which they provide a rapid and pow-
erful profiling. The HITChip thus provides a closed system,
which covers also phylotypes with low relative abundance
(below 0.02%). These are not accessible with conventional
sequencing depth [2,16] and therefore have been missed in
previous core analyses. However, overestimation of our core
size due to cross-hybridization of non-target phylotypes can-
not be excluded, and thus further studies are needed to ver-
ify the true dimensions of the common core microbiota.
In this study, the health status introduced much more var-
iation to the core than the sole number of studied subjects.
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FIG. 2. Definition of the common core microbiota. (a) Perspective plot visualizing the number of core phylotypes as a function of the prevalence
and abundance (indicated as logarithmic values of the signal intensity). (b) The common core size in 115 healthy subjects. The y-axis represents
the number of shared phylotypes at different abundance (logarithmic values of the signal intensity, x-axis).
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FIG. 3. Averaged, abundance-independent core size in 115 healthy
subjects. In order to refrain from using predefined abundance
thresholds in the definition of the core, an average core was calcu-
lated by bootstrapping the signal intensities and supposing 100%
prevalence. Dashed lines indicate the 95% confidence intervals of the
mean.
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We detected a smaller and markedly different core in UC
patients compared with healthy subjects (Fig. 3), in line with
the previous indication [7]. The smaller core of UC patients
suggests loss of certain health-specific core bacteria and
potentially more heterogeneous total microbiota as a proxy
of lost homeostasis. The latter would explain why it has
been difficult to find consistent, disease-specific microbiota
alterations.
In summary, our data indicate that when the full spectrum
of the highly uneven abundance distribution of intestinal phyl-
otypes is detected, one-third of the phylotypes are shared
among all the studied individuals. These bacteria can be seen
as a conserved community that does not co-vary, e.g. with
the genetic or dietary variation within individuals. The
remaining two-thirds of the phylotypes were shared to a var-
iable extent, i.e. between 114 and two individuals. It can be
speculated that bacteria outside the core are more strongly
influenced by the genotypic and environmental variation of
the subjects, and perhaps more susceptible to modulation.
Transparency Declaration
The authors declare that they have no conflicts of interest.
References
1. Zoetendal EG, Rajilic´-Stojanovic´ M, de Vos WM. High-throughput
diversity and functionality analysis of the gastrointestinal tract micro-
biota. Gut 2008; 57: 1605–1615.
2. Qin J, Li R, Raes J et al. A human gut microbial gene catalogue estab-
lished by metagenomic sequencing. Nature 2010; 464: 59–65.
3. Blaut M, Clavel T. Metabolic diversity of the intestinal microbiota:
implications for health and disease. J Nutr 2007; 137: 751S–755S.
4. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota
in human health and disease: the impact of probiotics. Genes Nutr
2011; 6: 209–240.
5. Tap J, Mondot S, Levenez F et al. Towards the human intestinal mic-
robiota phylogenetic core. Environ Microbiol 2009; 11: 2574–2584.
6. Turnbaugh PJ, Hamady M, Yatsunenko T et al. A core gut microbi-
ome in obese and lean twins. Nature 2009; 457: 480–484.
7. Willing B, Dicksved J, Halfvarson J et al. A pyrosequencing study in
twins shows that GI microbial profiles vary with inflammatory bowel
disease phenotypes. Gastroenterology 2010; 39: 1844–1854.
8. Sekelja M, Berget I, Naes T, Rudi K. Unveiling an abundant core mic-
robiota in the human adult colon by a phylogroup-independent
searching approach. ISME J 2010; 5: 519–531.
9. Rajilic-Stojanovic M, Heilig HG, Molenaar D et al. Development and
application of the human intestinal tract chip, a phylogenetic micro-
array: analysis of universally conserved phylotypes in the abundant
microbiota of young and elderly adults. Environ Microbiol 2009; 11:
1736–1751.
10. Jalanka-Tuovinen J, Salonen A, Nikkila¨ J et al. Intestinal microbiota in
healthy adults: temporal analysis reveals individual and common core
and relation to intestinal symptoms. PLoS ONE 2011; 6: e23035.
11. Bischoff SC. ‘Gut health’: a new objective in medicine? BMC Med
2011; 9: 24.
12. Nikkila¨ J, de Vos WM. Advanced approaches to characterize the
human intestinal microbiota by computational meta-analysis. J Clin
Gastroenterol 2010; 44: S2.
13. Lahti L, Elo LL, Aittokallio T, Kaski S. Probabilistic analysis of probe
reliability in differential gene expression studies with short oligonucleo-
tide arrays. IEEE/ACM Trans Comput Biol Bioinform 2011; 8: 217–225.
14. Becker RACJMWAR. The New S Language. London: Chapman & Hall,
1988; 702.
15. R Development CT. R: A Language and Environment for Statistical Com-
puting. Vienna: R Foundation for Statistical Computing, 2010.
16. Hamady M, Knight R. Microbial community profiling for human
microbiome projects: tools, techniques, and challenges. Genome Res
2009; 19: 1141.
Healthy
UC
40
28
93
Log intensity
2.0 2.5 3.0 3.5 4.0
0
10
0
20
0
30
0
40
0
N
um
be
r o
f p
hy
lo
ty
pe
s
Core from Healthy
Core from Healthy+UC
Core from UC
(a) (b)
FIG. 4. Impact of health status in the common core microbiota. (a) The core size of the intestinal microbiota of 12 healthy subjects (black), 12
patients suffering from UC (red) and their pooled combination (blue) was calculated by bootstrapping. Dashed lines indicate the 95% confidence
intervals for the healthy core. (b) Venn diagram showing the compositional overlap between the UC and healthy core. The phylotypes constitut-
ing the cores were compared as explained in detail in the text.
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